Moderna (MRNA) Protective Put Calculator
Calculator · free · no signup · MRNAPrice a protective put, zero-cost collar, or put spread on Moderna. Annual cost, max loss, upside cap, tax treatment, auto-filled from current MRNA option chain.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.
Request beta access →Related calculators: Stock Concentration Calculator
About Moderna
Moderna (MRNA) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in Cambridge, MA.
Last close: $192.57 per share (as of 2026-10-01).
Equity grants at Moderna typically include restricted stock units (RSUs).
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Source: Wikipedia (CC BY-SA 4.0)
Founded in Cambridge, Massachusetts in 2010 around messenger RNA, the company had no approved product until Spikevax, developed with the National Institutes of Health and authorized in December 2020, produced tens of billions in revenue over two years. That demand collapsed as the pandemic receded, returning the company to heavy research spending against a pipeline of respiratory syncytial virus, influenza, cytomegalovirus, and individualized cancer vaccines with Merck. The platform argument is speed: designing a vaccine from a genetic sequence rather than growing virus.
Sources: modernatx.com · en.wikipedia.org
Equity comp at Moderna
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Moderna.
A protective put caps your downside on the MRNA position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current MRNA option chain, with annual cost, max loss, and tax-treatment notes.
Example: a 5,000-share MRNA position at $192.57 is worth $962,850. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $19,257 to $38,514) before any premium offset from a short call. The calculator prices both structures off MRNA's current option chain so you see the actual cost for your chosen floor, tenor, and cap.
All Moderna tools → · Use the generic Protect Your Stock Calculator for any company.
Moderna equity questions
- How much does it cost to hedge MRNA stock?
- The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and MRNA's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current MRNA option chain and shows the annual cost, maximum loss, and tax treatment.
- Does Moderna grant ISOs, NSOs, or RSUs?
- Equity compensation at Moderna typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Moderna RSUs use double-trigger vesting?
- No. Moderna restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Moderna equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.